Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-09-10

FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved Actavis's supplemental application for a generic lisinopril and hydrochlorothiazide tablet, expanding the approval to include a lisinopril/HCTZ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lisinopril and Hydrochlorothiazide (Lisinopril and Hydrochlorothiazide)

Snippet

SUPPL AP for LISINOPRIL AND HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE)